奥美医疗
(002950)
| 流通市值：50.26亿 | | | 总市值：70.42亿 |
| 流通股本：4.52亿 | | | 总股本：6.33亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,596,602,769 | 1,676,335,750.73 | 758,656,819.43 | 3,326,292,089.93 |
| 营业收入 | 2,596,602,769 | 1,676,335,750.73 | 758,656,819.43 | 3,326,292,089.93 |
| 二、营业总成本 | 2,188,956,656.67 | 1,422,703,633.9 | 659,488,618.5 | 2,873,903,377.52 |
| 营业成本 | 1,818,887,281.82 | 1,179,550,690.46 | 527,146,585.71 | 2,368,862,143.45 |
| 税金及附加 | 22,919,344.17 | 13,865,586.07 | 4,469,830.84 | 18,498,272.31 |
| 销售费用 | 78,699,980.65 | 51,164,376.66 | 23,998,289.19 | 95,911,944.91 |
| 管理费用 | 192,534,208.85 | 128,159,419.23 | 74,860,073.5 | 281,930,049.23 |
| 研发费用 | 76,595,392.83 | 58,829,055.89 | 29,820,611.27 | 106,370,339.78 |
| 财务费用 | -679,551.65 | -8,865,494.41 | -806,772.01 | 2,330,627.84 |
| 其中:利息费用 | 10,040,608.79 | 7,881,655.41 | 4,856,618.89 | 25,525,930.31 |
| 其中:利息收入 | 10,458,560.82 | 7,501,407.43 | 2,084,624.44 | 7,164,858.07 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 4,226,382.65 | 4,508,565.76 | 4,613,134.1 | -21,906,897.02 |
| 加:投资收益 | -4,891,127.11 | -5,470,979.88 | -974,588.28 | -1,369,487.3 |
| 资产处置收益 | 16,906.76 | 16,906.76 | 46,472.2 | 28,789,418.21 |
| 资产减值损失(新) | -14,988,058.97 | -19,558,742.31 | -2,903,438.16 | -32,813,416.9 |
| 信用减值损失(新) | 3,137,092.88 | 34,839.99 | 1,575,844.66 | -3,054,803.11 |
| 其他收益 | 33,452,863.14 | 18,431,505.4 | 11,120,961.92 | 36,431,206.55 |
| 四、营业利润 | 428,600,171.68 | 251,594,212.55 | 112,646,587.37 | 458,464,732.84 |
| 加:营业外收入 | 646,640.6 | 623,948.57 | 18,136.54 | 2,051,015.01 |
| 减:营业外支出 | 1,316,855.9 | 1,159,371.28 | 1,042,744.56 | 6,124,486.99 |
| 五、利润总额 | 427,929,956.38 | 251,058,789.84 | 111,621,979.35 | 454,391,260.86 |
| 减:所得税费用 | 73,043,733.06 | 47,681,747.86 | 24,969,103.69 | 85,594,588.75 |
| 六、净利润 | 354,886,223.32 | 203,377,041.98 | 86,652,875.66 | 368,796,672.11 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 354,886,223.32 | 203,377,041.98 | 86,652,875.66 | 368,796,672.11 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 348,804,421.31 | 199,835,374.92 | 86,502,742.68 | 368,679,147.09 |
| 少数股东损益 | 6,081,802.01 | 3,541,667.06 | 150,132.98 | 117,525.02 |
| 扣除非经常损益后的净利润 | 309,182,865.98 | 185,262,341.13 | 74,064,711.29 | 343,356,546.28 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.55 | 0.32 | 0.14 | 0.59 |
| (二)稀释每股收益 | 0.55 | 0.32 | 0.14 | 0.59 |
| 八、其他综合收益 | 651,981.93 | 938,093.16 | 651,010.9 | -19,137,263.29 |
| 归属于母公司股东的其他综合收益 | 651,981.93 | 938,093.16 | 651,010.9 | -19,137,263.29 |
| 九、综合收益总额 | 355,538,205.25 | 204,315,135.14 | 87,303,886.56 | 349,659,408.82 |
| 归属于母公司股东的综合收益总额 | 349,456,403.24 | 200,773,468.08 | 87,153,753.58 | 349,541,883.8 |
| 归属于少数股东的综合收益总额 | 6,081,802.01 | 3,541,667.06 | 150,132.98 | 117,525.02 |
| 公告日期 | 2025-10-30 | 2025-08-27 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |